Saudi Critical Care Journal

LETTER TO THE EDITOR
Year
: 2021  |  Volume : 5  |  Issue : 4  |  Page : 71--72

Ibrutinib platelet dysfunction induced intracranial hemorrhage management with activated factor VII and transfusion of platelets


Tariq Janjua1, Luis Rafael Moscote-Salazar2 
1 Department of Critical Care, Regions Hospital, Saint Paul, MN, USA
2 Department of Critical Care, Latinamerican Council of Neurocritical Care; Center of Biomedical Research, Universidad de Cartagena, Cartagena; Department of Critical Care, Critical Care Unit, Centro Policlinico del Olaya; Department of Critical Care, Colombian Clinical Research Group in Neurocritical Care, Bogota, Colombia

Correspondence Address:
Luis Rafael Moscote-Salazar
Center of Biomedical Research, Universidad de Cartagena, Cartagena
Colombia




How to cite this article:
Janjua T, Moscote-Salazar LR. Ibrutinib platelet dysfunction induced intracranial hemorrhage management with activated factor VII and transfusion of platelets.Saudi Crit Care J 2021;5:71-72


How to cite this URL:
Janjua T, Moscote-Salazar LR. Ibrutinib platelet dysfunction induced intracranial hemorrhage management with activated factor VII and transfusion of platelets. Saudi Crit Care J [serial online] 2021 [cited 2022 Jan 17 ];5:71-72
Available from: https://www.sccj-sa.org/article.asp?issn=2543-1854;year=2021;volume=5;issue=4;spage=71;epage=72;aulast=Janjua;type=0